Coeptis Reconciled Depreciation vs Cost Of Revenue Analysis
| COEP Stock | USD 0.20 0.01 5.26% |
Coeptis Therapeutics financial indicator trend analysis is way more than just evaluating Coeptis Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Coeptis Therapeutics is a good investment. Please check the relationship between Coeptis Therapeutics Reconciled Depreciation and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.
Reconciled Depreciation vs Cost Of Revenue
Reconciled Depreciation vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Coeptis Therapeutics Reconciled Depreciation account and Cost Of Revenue. At this time, the significance of the direction appears to have very week relationship.
The correlation between Coeptis Therapeutics' Reconciled Depreciation and Cost Of Revenue is 0.23. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Coeptis Therapeutics, assuming nothing else is changed. The correlation between historical values of Coeptis Therapeutics' Reconciled Depreciation and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Coeptis Therapeutics are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Reconciled Depreciation i.e., Coeptis Therapeutics' Reconciled Depreciation and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | 0.23 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Reconciled Depreciation
Cost Of Revenue
Cost of Revenue is found on Coeptis Therapeutics income statement and represents the costs associated with goods and services Coeptis Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Coeptis Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Coeptis Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.As of 11/30/2024, Issuance Of Capital Stock is likely to grow to about 5 M, while Selling General Administrative is likely to drop slightly above 24.3 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 14.1M | 34.2M | 39.3M | 41.3M | Depreciation And Amortization | 447.4K | 228.5K | 1.0M | 616.3K |
Coeptis Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Coeptis Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Coeptis Therapeutics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Current Liabilities | 155.9K | 5.3M | 2.8M | 1.8M | 2.1M | 2.2M | |
| Retained Earnings | (9.3K) | (14.1M) | (27.6M) | (65.7M) | (59.2M) | (56.2M) | |
| Accounts Payable | 450.0 | 1.6M | 134.1K | 99.0K | 89.1K | 84.7K | |
| Total Current Assets | 505.0 | 224.8K | 2.2M | 3.9M | 4.5M | 4.8M | |
| Common Stock | 25K | 2.5K | 3.6K | 2.0K | 1.8K | 1.7K | |
| Net Tangible Assets | (378.5K) | (5.1M) | 2.4M | 4.8M | 5.5M | 5.8M |
Pair Trading with Coeptis Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coeptis Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Coeptis Stock
| 0.57 | HLN | Haleon plc | PairCorr |
| 0.55 | ELAN | Elanco Animal Health | PairCorr |
| 0.51 | ZTS | Zoetis Inc | PairCorr |
| 0.44 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.41 | TAK | Takeda Pharmaceutical | PairCorr |
The ability to find closely correlated positions to Coeptis Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coeptis Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coeptis Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coeptis Therapeutics to buy it.
The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coeptis Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coeptis Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coeptis Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.